▶ 調査レポート

医薬品有効成分(API)の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Active Pharmaceutical Ingredient (API) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。医薬品有効成分(API)の世界市場2020年:企業別、地域別、種類・用途別 / Global Active Pharmaceutical Ingredient (API) Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-00477資料のイメージです。• レポートコード:D0GIR-00477
• 出版社/出版日:GlobalInfoResearch / 2020年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、医薬品有効成分(API)の世界市場を広く調査・分析し、今後の市場展望をまとめております。医薬品有効成分(API)の種類別市場規模(革新的APISセグメント、ジェネリックAPISセグメント)、用途別市場規模(腫瘍、糖尿病、心血管疾患、中枢神経疾患、整形外科疾患、腎臓病、眼科、呼吸器疾患、消化器疾患)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Teva、Albemarle、Sun Pharmaceutical、Allergan、Aurobindo Pharma、Mylan、Sigma-Aldrich
・地域別グローバル市場分析 2015年-2020年
・医薬品有効成分(API)の北米市場(アメリカ、カナダ、メキシコ)
・医薬品有効成分(API)のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・医薬品有効成分(API)のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・医薬品有効成分(API)の南米市場(ブラジル、アルゼンチン)
・医薬品有効成分(API)の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:革新的APISセグメント、ジェネリックAPISセグメント
・用途別分析:腫瘍、糖尿病、心血管疾患、中枢神経疾患、整形外科疾患、腎臓病、眼科、呼吸器疾患、消化器疾患
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Active Pharmaceutical Ingredient (API) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.3% in the forecast period of 2020 to 2025 and will expected to reach USD 83030 million by 2025, from USD 65040 million in 2019.

The Active Pharmaceutical Ingredient (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Active Pharmaceutical Ingredient (API) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Active Pharmaceutical Ingredient (API) market has been segmented into:
Innovative APIS Segment
Generic APIS Segment

By Application, Active Pharmaceutical Ingredient (API) has been segmented into:
Oncology
Diabetes
Cardiovascular Disease
Cns and Neurological Disorders
Orthopedic Disorders
Nephrology
Ophthalmology
Pulmonology
Gastrointestinal Disorders

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Active Pharmaceutical Ingredient (API) market presented in the report. This section sheds light on the sales growth of different regional and country-level Active Pharmaceutical Ingredient (API) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Active Pharmaceutical Ingredient (API) market.

The report offers in-depth assessment of the growth and other aspects of the Active Pharmaceutical Ingredient (API) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Active Pharmaceutical Ingredient (API) Market Share Analysis
Active Pharmaceutical Ingredient (API) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Active Pharmaceutical Ingredient (API) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Active Pharmaceutical Ingredient (API) sales, revenue and market share for each player covered in this report.

The major players covered in Active Pharmaceutical Ingredient (API) are:
Teva
Albemarle
Sun Pharmaceutical
Allergan
Aurobindo Pharma
Mylan
Sigma-Aldrich

レポート目次

Table of Contents

1 Active Pharmaceutical Ingredient (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredient (API)
1.2 Classification of Active Pharmaceutical Ingredient (API) by Type
1.2.1 Global Active Pharmaceutical Ingredient (API) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Type in 2019
1.2.3 Innovative APIS Segment
1.2.4 Generic APIS Segment
1.3 Global Active Pharmaceutical Ingredient (API) Market by Application
1.3.1 Overview: Global Active Pharmaceutical Ingredient (API) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 Cns and Neurological Disorders
1.3.6 Orthopedic Disorders
1.3.7 Nephrology
1.3.8 Ophthalmology
1.3.9 Pulmonology
1.3.10 Gastrointestinal Disorders
1.4 Global Active Pharmaceutical Ingredient (API) Market by Regions
1.4.1 Global Active Pharmaceutical Ingredient (API) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Active Pharmaceutical Ingredient (API) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Active Pharmaceutical Ingredient (API) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Active Pharmaceutical Ingredient (API) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Active Pharmaceutical Ingredient (API) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Active Pharmaceutical Ingredient (API) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Active Pharmaceutical Ingredient (API) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Albemarle
2.2.1 Albemarle Details
2.2.2 Albemarle Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Albemarle SWOT Analysis
2.2.4 Albemarle Product and Services
2.2.5 Albemarle Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sun Pharmaceutical SWOT Analysis
2.3.4 Sun Pharmaceutical Product and Services
2.3.5 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aurobindo Pharma
2.5.1 Aurobindo Pharma Details
2.5.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aurobindo Pharma SWOT Analysis
2.5.4 Aurobindo Pharma Product and Services
2.5.5 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sigma-Aldrich
2.7.1 Sigma-Aldrich Details
2.7.2 Sigma-Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sigma-Aldrich SWOT Analysis
2.7.4 Sigma-Aldrich Product and Services
2.7.5 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Active Pharmaceutical Ingredient (API) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Active Pharmaceutical Ingredient (API) Players Market Share
3.2.2 Top 10 Active Pharmaceutical Ingredient (API) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Regions
4.2 North America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
4.3 Europe Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
4.5 South America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
5 North America Active Pharmaceutical Ingredient (API) Revenue by Countries
5.1 North America Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
5.2 USA Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
5.3 Canada Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
5.4 Mexico Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
6 Europe Active Pharmaceutical Ingredient (API) Revenue by Countries
6.1 Europe Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
6.2 Germany Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
6.3 UK Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
6.4 France Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
6.5 Russia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
6.6 Italy Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Countries
7.1 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
7.2 China Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
7.3 Japan Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
7.4 Korea Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
7.5 India Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
8 South America Active Pharmaceutical Ingredient (API) Revenue by Countries
8.1 South America Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
8.2 Brazil Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
8.3 Argentina Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Active Pharmaceutical Ingredient (API) by Countries
9.1 Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
9.3 UAE Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
9.4 Egypt Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
9.5 South Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2015-2020)
10.2 Global Active Pharmaceutical Ingredient (API) Market Forecast by Type (2019-2024)
10.3 Innovative APIS Segment Revenue Growth Rate (2015-2025)
10.4 Generic APIS Segment Revenue Growth Rate (2015-2025)
11 Global Active Pharmaceutical Ingredient (API) Market Segment by Application
11.1 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2015-2020)
11.2 Active Pharmaceutical Ingredient (API) Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Diabetes Revenue Growth (2015-2020)
11.5 Cardiovascular Disease Revenue Growth (2015-2020)
11.6 Cns and Neurological Disorders Revenue Growth (2015-2020)
11.7 Orthopedic Disorders Revenue Growth (2015-2020)
11.8 Nephrology Revenue Growth (2015-2020)
11.9 Ophthalmology Revenue Growth (2015-2020)
11.10 Pulmonology Revenue Growth (2015-2020)
11.11 Gastrointestinal Disorders Revenue Growth (2015-2020)
12 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2021-2025)
12.1 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2021-2025)
12.2 Global Active Pharmaceutical Ingredient (API) Market Forecast by Regions (2021-2025)
12.3 North America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
12.4 Europe Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
12.6 South America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Active Pharmaceutical Ingredient (API) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Active Pharmaceutical Ingredient (API) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Active Pharmaceutical Ingredient (API) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Active Pharmaceutical Ingredient (API) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Teva Corporate Information, Location and Competitors
Table 6. Teva Active Pharmaceutical Ingredient (API) Major Business
Table 7. Teva Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2017-2018)
Table 8. Teva SWOT Analysis
Table 9. Teva Active Pharmaceutical Ingredient (API) Product and Solutions
Table 10. Teva Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Albemarle Corporate Information, Location and Competitors
Table 12. Albemarle Active Pharmaceutical Ingredient (API) Major Business
Table 13. Albemarle Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2018-2019)
Table 14. Albemarle SWOT Analysis
Table 15. Albemarle Active Pharmaceutical Ingredient (API) Product and Solutions
Table 16. Albemarle Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sun Pharmaceutical Corporate Information, Location and Competitors
Table 18. Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Major Business
Table 19. Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2017-2018)
Table 20. Sun Pharmaceutical SWOT Analysis
Table 21. Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Solutions
Table 22. Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Corporate Information, Location and Competitors
Table 24. Allergan Active Pharmaceutical Ingredient (API) Major Business
Table 25. Allergan Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2017-2018)
Table 26. Allergan SWOT Analysis
Table 27. Allergan Active Pharmaceutical Ingredient (API) Product and Solutions
Table 28. Allergan Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Aurobindo Pharma Corporate Information, Location and Competitors
Table 30. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Major Business
Table 31. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2017-2018)
Table 32. Aurobindo Pharma SWOT Analysis
Table 33. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product and Solutions
Table 34. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Mylan Corporate Information, Location and Competitors
Table 36. Mylan Active Pharmaceutical Ingredient (API) Major Business
Table 37. Mylan Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2017-2018)
Table 38. Mylan SWOT Analysis
Table 39. Mylan Active Pharmaceutical Ingredient (API) Product and Solutions
Table 40. Mylan Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sigma-Aldrich Corporate Information, Location and Competitors
Table 42. Sigma-Aldrich Active Pharmaceutical Ingredient (API) Major Business
Table 43. Sigma-Aldrich Active Pharmaceutical Ingredient (API) Total Revenue (USD Million) (2017-2018)
Table 44. Sigma-Aldrich SWOT Analysis
Table 45. Sigma-Aldrich Active Pharmaceutical Ingredient (API) Product and Solutions
Table 46. Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Players (2015-2020)
Table 48. Global Active Pharmaceutical Ingredient (API) Revenue Share by Players (2015-2020)
Table 49. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions (2015-2020)
Table 51. North America Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
Table 52. North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Table 53. Europe Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Active Pharmaceutical Ingredient (API) Revenue by Countries (2015-2020)
Table 56. South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Table 59. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Type (2015-2020)
Table 60. Global Active Pharmaceutical Ingredient (API) Revenue Share by Type (2015-2020)
Table 61. Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2021-2025)
Table 62. Global Active Pharmaceutical Ingredient (API) Revenue by Application (2015-2020)
Table 63. Global Active Pharmaceutical Ingredient (API) Revenue Share by Application (2015-2020)
Table 64. Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2021-2025)
Table 65. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Active Pharmaceutical Ingredient (API) Picture
Figure 2. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Type in 2019
Figure 3. Innovative APIS Segment Picture
Figure 4. Generic APIS Segment Picture
Figure 5. Active Pharmaceutical Ingredient (API) Revenue Market Share by Application in 2019
Figure 6. Oncology Picture
Figure 7. Diabetes Picture
Figure 8. Cardiovascular Disease Picture
Figure 9. Cns and Neurological Disorders Picture
Figure 10. Orthopedic Disorders Picture
Figure 11. Nephrology Picture
Figure 12. Ophthalmology Picture
Figure 13. Pulmonology Picture
Figure 14. Gastrointestinal Disorders Picture
Figure 15. Global Active Pharmaceutical Ingredient (API) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Active Pharmaceutical Ingredient (API) Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Active Pharmaceutical Ingredient (API) Revenue Market Share in 2019
Figure 24. Global Top 10 Players Active Pharmaceutical Ingredient (API) Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions (2015-2020)
Figure 28. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions in 2018
Figure 29. North America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 30. Europe Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 32. South America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 34. North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Figure 35. North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2019
Figure 36. USA Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 37. Canada Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 39. Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2019
Figure 41. Germany Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 42. UK Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 43. France Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 44. Russia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 45. Italy Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2019
Figure 48. China Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 49. Japan Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 50. Korea Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 51. India Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 53. South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Figure 54. South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2019
Figure 55. Brazil Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 60. UAE Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2015-2020)
Figure 63. Global Active Pharmaceutical Ingredient (API) Revenue Share by Type (2015-2020)
Figure 64. Global Active Pharmaceutical Ingredient (API) Revenue Share by Type in 2019
Figure 65. Global Active Pharmaceutical Ingredient (API) Market Share Forecast by Type (2021-2025)
Figure 66. Global Innovative APIS Segment Revenue Growth Rate (2015-2020)
Figure 67. Global Generic APIS Segment Revenue Growth Rate (2015-2020)
Figure 68. Global Active Pharmaceutical Ingredient (API) Revenue Share by Application (2015-2020)
Figure 69. Global Active Pharmaceutical Ingredient (API) Revenue Share by Application in 2019
Figure 70. Global Active Pharmaceutical Ingredient (API) Market Share Forecast by Application (2021-2025)
Figure 71. Global Oncology Revenue Growth Rate (2015-2020)
Figure 72. Global Diabetes Revenue Growth Rate (2015-2020)
Figure 73. Global Cardiovascular Disease Revenue Growth Rate (2015-2020)
Figure 74. Global Cns and Neurological Disorders Revenue Growth Rate (2015-2020)
Figure 75. Global Orthopedic Disorders Revenue Growth Rate (2015-2020)
Figure 76. Global Nephrology Revenue Growth Rate (2015-2020)
Figure 77. Global Ophthalmology Revenue Growth Rate (2015-2020)
Figure 78. Global Pulmonology Revenue Growth Rate (2015-2020)
Figure 79. Global Gastrointestinal Disorders Revenue Growth Rate (2015-2020)
Figure 80. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
Figure 84. Europe Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
Figure 86. South America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel